Orange Book product · Brand (NDA)
VERSACLOZ
CLOZAPINE
At a glance
Feb 06, 2013
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 06, 2013
13 yr 7 mo ago
Today
Patent 8057811 expires
Listed drug product patent expiration.
May 01, 2028
in 1 yr 11 mo
Pharmaceutical detail
Active ingredient
CLOZAPINE
Strength
50MG/ML
Dosage form
SUSPENSION
Route
ORAL
TE code
Not listed
Application
NDA 203479
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2007FAZACLO ODTBrand (NDA)
NDA 021590 · JAZZ
- 1989CLOZARILBrand (NDA)
NDA 019758 · HERITAGE LIFE
- 2024CLOZAPINEGeneric (ANDA)
ANDA 212923 · AUROBINDO PHARMA
- 2018CLOZAPINEGeneric (ANDA)
ANDA 090308 · BARR LABS INC
- 2017CLOZAPINEGeneric (ANDA)
ANDA 209480 · ZYDUS PHARMS
- 2016CLOZAPINEGeneric (ANDA)
ANDA 206433 · AUROBINDO PHARMA
- 2015CLOZAPINEGeneric (ANDA)
ANDA 202873 · ACCORD HLTHCARE
- 2015CLOZAPINEGeneric (ANDA)
ANDA 203807 · DR REDDYS LABS SA
- 2015CLOZAPINEGeneric (ANDA)
ANDA 201824 · MYLAN
- 2010CLOZAPINEGeneric (ANDA)
ANDA 075417 · MYLAN
- 2005CLOZAPINEGeneric (ANDA)
ANDA 076809 · IVAX SUB TEVA PHARMS
- 2005CLOZAPINEGeneric (ANDA)
ANDA 075162 · PAR PHARM
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8057811 | May 01, 2028 | in 1 yr 11 mo | Product |

